![Kenneth Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hoberman
Directeur des opérations chez
STEMLINE THERAPEUTICS, INC.
Fortune : 18 M $ au 30/06/2026
Profil
Kenneth Hoberman is Vice Chairman at Lirum Therapeutics, Inc. since 2021.
Mr. Hoberman is Independent Director at TG Therapeutics, Inc. since 2014.
Mr. Hoberman is Independent Director at Nuvectis Pharma, Inc. since 2021.
Mr. Hoberman is Chief Operating Officer at Stemline Therapeutics, Inc. since 2013.
Mr. Hoberman was Vice President-Corporate & Business Development at Keryx Biopharmaceuticals, Inc. from 2004 to 2012.
Mr. Hoberman completed undergraduate studies at Boston University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 279 653 ( 0,18% ) | 15 M $ | 30/06/2026 | |
| 11/06/2026 | 168 140 ( 0,63% ) | 3 M $ | 30/06/2026 |
Postes actifs de Kenneth Hoberman
| Sociétés | Poste | Début |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Directeur des opérations | 01/01/2013 |
| TG THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/12/2014 |
| NUVECTIS PHARMA, INC. | Directeur/Membre du Conseil | 01/07/2021 |
| LIRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2021 |
Anciens postes connus de Kenneth Hoberman
| Sociétés | Poste | Fin |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 01/01/2012 |
Formation de Kenneth Hoberman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
